Immunicom’s Immunotherapy Product Receives US FDA Breakthrough Device Designation for the Treatment of Cancer – PR Newswire (press release)
|
Immunicom's Immunotherapy Product Receives US FDA Breakthrough Device Designation for the Treatment of Cancer
PR Newswire (press release) In contrast to immunotherapy pharmaceuticals and biologicals that introduce foreign compounds and material into a patient's body, and which are often accompanied by negative side effects, Immunicom's patented technology is based on a "subtractive" … |
